Choline Metabolic Profiling by Magnetic Resonance Spectroscopy
The revised version of cancer hallmarks, depicting the biological properties acquired during tumor development and progression, includes the capability to modify or reprogram cellular metabolism. High-resolution multinuclear magnetic resonance spectroscopy (MRS) provides noninvasive means of monitoring metabolites that play a central role in several pathways, measuring the rates at which reactions within the pathways take place, and investigating how these rates are controlled in such a way that a metabolic precursor and cofactors are provided according to the demand. Here we describe comprehensive methods for assaying the activity of key enzymes involved in the phosphatidylcholine metabolic pathways responsible for phosphocholine accumulation in ovarian cancer cells using high-resolution 1 H and 31 P MRS analyses of cell lysates or cytosolic preparations.
- Xenopus Cell-Free Extracts to Study the DNA Damage Response
- Assessment of Predictive Values of Tumor Markers
- Antigen-Pulsed Dendritic Cell Approach to Melanoma
- Matrix Metalloproteinases and Their Inhibitors
- Electrophoretic Mobility Shift Analysis of the DNA Binding of Tumor Suppressor Gene Products
- Neuroendocrine Phenotype of Small Cell Lung Cancer
- Regulation of Angiostatin Mobilization by Tumor-Derived Matrix Metalloproteinase-2
- Representational Difference Analysis of Gene Expression
- Yeast Two-Hybrid Screening as a Means of Deciphering Tumor Suppressor Pathways
- 报告基因检测技术